newsfilter
← Latest News
GlobeNewswire·

Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026

WILMINGTON, Del., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (NASDAQ:IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing IKT-001, a novel